Neil Almstead
2021
In 2021, Neil Almstead earned a total compensation of $4.3M as Chief Technical Operations Officer at PTC Therapeutics, a 10% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $294,300 |
|---|---|
| Option Awards | $2,790,550 |
| Salary | $496,583 |
| Stock Awards | $678,198 |
| Other | $19,938 |
| Total | $4,279,569 |
Almstead received $2.8M in option awards, accounting for 65% of the total pay in 2021.
Almstead also received $294.3K in non-equity incentive plan, $496.6K in salary, $678.2K in stock awards and $19.9K in other compensation.
Rankings
In 2021, Neil Almstead's compensation ranked 3,106th out of 12,415 executives tracked by ExecPay. In other words, Almstead earned more than 75.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,106 out of 12,415 | 75th |
Division Manufacturing | 1,246 out of 5,505 | 77th |
Major group Chemicals And Allied Products | 503 out of 2,375 | 79th |
Industry group Drugs | 445 out of 2,096 | 79th |
Industry Pharmaceutical Preparations | 305 out of 1,546 | 80th |
Source: SEC filing on April 28, 2022.
Almstead's colleagues
We found four more compensation records of executives who worked with Neil Almstead at PTC Therapeutics in 2021.